Abingworth LLP: A transatlantic venture capital firm investing in bioscience, healthcare, and IT since 1973.
Location
London, Greater London, GB
Founded
1973
Abingworth is a transatlantic venture capital firm specializing in life science and healthcare investments. With a focus on bioscience and biotechnology, the firm invests across various stages, from early-stage to late-stage and public companies. Abingworth typically participates in Series A to Series D rounds, with investments ranging from $15 million to $30 million per company.
Notable portfolio companies include Alnylam Pharmaceuticals, Clovis Oncology, and Scorpion Therapeutics. Founded in 1973, Abingworth has a long-standing reputation in the industry and offers value-add services to its portfolio companies, leveraging its extensive network and expertise in the life sciences sector. The firm's team comprises experienced investment professionals and scientific advisors who work closely with entrepreneurs to develop breakthrough medicines and technologies.
Abingworth - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
